Alnylam Pharmaceuticals (ALNY)
NASDAQ:ALNY
Advertisement

Alnylam Pharma (ALNY) Similar Stocks

Compare
1,345 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Alnylam Pharma
$449.16
$59.34B
1,868.39
90.68%
19 Buy
4 Hold
0 Sell
Strong Buy
Incyte
$104.15
$20.45B
17.47
37.27%
7 Buy
10 Hold
1 Sell
Moderate Buy
Vertex Pharmaceuticals
$437.15
$110.16B
30.62
-6.13%
14 Buy
8 Hold
0 Sell
Moderate Buy
Argenx Se
$907.98
$55.82B
42.65
60.93%
20 Buy
1 Hold
0 Sell
Strong Buy
Genmab
$30.26
$18.85B
12.74
46.96%
5 Buy
1 Hold
1 Sell
Moderate Buy
BioNTech SE
$103.09
$26.86B
3.38%
12 Buy
3 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ALNY
Alnylam Pharma
449.16
216.89
93.38%
INCY
Incyte
104.15
27.18
35.31%
VRTX
Vertex Pharmaceuticals
437.15
-29.86
-6.39%
ARGX
Argenx Se
907.98
340.08
59.88%
GMAB
Genmab
30.26
9.59
46.40%
BNTX
BioNTech SE
103.09
1.22
1.20%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis